Physitrack PLC (PTRK)

Currency in SEK
13.05
0.00(0.00%)
Closed·
PTRK is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
12.8513.15
52 wk Range
8.0221.70
Key Statistics
Prev. Close
13.05
Open
12.85
Day's Range
12.85-13.15
52 wk Range
8.02-21.7
Volume
11.68K
Average Volume (3m)
34.03K
1-Year Change
51.74%
Book Value / Share
12.05
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
PTRK Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Valuation implies a strong free cash flow yield

Physitrack PLC News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Strong Buy
Moving Averages
Sell

Physitrack PLC Company Profile

Physitrack PLC, together with its subsidiaries, provides digital healthcare solutions in the United Kingdom, Europe, North America, and internationally. It operates through Lifecare and Wellness segments. The company offers Physitrack, a remote therapeutic monitoring platform that provides a suite of tools for exercise program prescription, patient-reported adherence and tracking, and telehealth for private practices, occupational health and case management, healthcare systems and hospitals, and sports. It also provides Physiapp, a mobile application that allows physiotherapists to deliver personalized rehabilitation programs, track patient progress, and adjust treatments in real-time; and Physiocourses, an e-learning library for healthcare professionals. Physitrack PLC was incorporated in 2012 and is based in London, the United Kingdom.

Physitrack PLC Earnings Call Summary for Q3/2025

  • Revenue grew 6% YoY to €3.5M; free cash flow improved 200%; stock fell 14.4% to €16.05 post-earnings
  • Adjusted EBITDA up 25% to €1.2M (33% margin); Annual Recurring Revenue rose 10% to €12.7M
  • Company targets doubling revenue and 40-45% EBITDA margin; focuses on North American expansion and AI development
  • CEO emphasizes robust SaaS model; CFO highlights operational efficiency for accelerated development
  • Risks include market competition, economic uncertainty, currency fluctuations, and potential regulatory changes
Last Updated: 10/21/2025, 09:58 PM
Read Full Transcript

Compare PTRK to Peers and Sector

Metrics to compare
PTRK
Peers
Sector
Relationship
P/E Ratio
−3.1x−7.0x−0.6x
PEG Ratio
0.010.010.00
Price/Book
1.1x4.7x2.6x
Price / LTM Sales
1.2x5.9x3.2x
Upside (Analyst Target)
72.5%10.3%41.8%
Fair Value Upside
Unlock−16.5%5.1%Unlock
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Earnings

Latest Release
Oct 21, 2025
EPS / Forecast
-0.02 / --
Revenue / Forecast
3.46M / --
EPS Revisions
Last 90 days

PTRK Income Statement

FAQ

What Is the Physitrack (PTRK) Stock Price Today?

The Physitrack stock price today is 13.05

What Stock Exchange Does Physitrack Trade On?

Physitrack is listed and trades on the Stockholm Stock Exchange stock exchange.

What Is the Stock Symbol for Physitrack?

The stock symbol for Physitrack is "PTRK."

What Is the Physitrack Market Cap?

As of today, Physitrack market cap is 212.20M.

What Is Physitrack's Earnings Per Share (TTM)?

The Physitrack EPS (TTM) is -0.39.

From a Technical Analysis Perspective, Is PTRK a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.

How Many Times Has Physitrack Stock Split?

Physitrack has split 0 times.

How Many Employees Does Physitrack Have?

Physitrack has 64 employees.

What is the current trading status of Physitrack (PTRK)?

As of Dec 24, 2025, Physitrack (PTRK) is trading at a price of 13.05, with a previous close of 13.05. The stock has fluctuated within a day range of 12.85 to 13.15, while its 52-week range spans from 8.02 to 21.70.

What Is Physitrack (PTRK) Price Target According to Analysts?

The average 12-month price target for Physitrack is SEK22.51891892, with a high estimate of SEK22.51891892 and a low estimate of SEK22.51891892. 0 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +72.56% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.